Prevalence of Hepatitis B Co-infection Amongst HIV Infected Children Attending a Care and Treatment Centre in Owerri, South-eastern Nigeria
Overview
Affiliations
Introduction: Hepatitis B infection impacts negatively on disease progression in HIV infected children thereby increasing morbidity and mortality. In spite of the foregoing, there is paucity of data on Hepatitis B co-infection in children living with HIV in Owerri, South Eastern Nigeria.This study set out to determine the prevalence of Hepatitis B Co- infection in HIV infected children attending the Paediatric HIV Care and Treatment clinic of the Federal Medical Centre Owerri.
Methods: The study period was between February and July 2010. Testing for Hepatitis B infection was done using the ACON Hepatitis B surface antigen Rapid test strip. (Acon Laboratories Inc. San Diego.CA).
Results: A total of 139 HIV infected children were enrolled during the study period. The overall prevalence of Hepatitis B Co- infection was 5.8% (8/139). The prevalence in males was 8.2% (5/61) while in females it was 3.8% (3/78). The prevalence of Hepatitis B Co- infection amongst patients on antiretroviral therapy was 4.6%. They accounted for 62.5% of Hepatitis B Co- infection in our study. Previous blood transfusion, gender and age of patient did not show statistically significant relationship with Hepatitis B Co-infection.
Conclusion: Though our study shows a low prevalence of Hepatitis B co infection in HIV infected children in our centre, reduction of the rate is still strongly desirable. Reduction can be achieved by strengthening the uptake of Hepatitis B vaccine as part of the routine childhood immunization programme.
Fofana D, Somboro A, Maiga M, Kampo M, Diakite B, Cissoko Y Int J Environ Res Public Health. 2023; 20(5).
PMID: 36901164 PMC: 10002029. DOI: 10.3390/ijerph20054142.
Eleje G, Onubogu C, Fiebai P, Mbachu I, Akaba G, Loto O SAGE Open Med. 2022; 10:20503121221095411.
PMID: 35509955 PMC: 9058348. DOI: 10.1177/20503121221095411.
Lawal M, Adeniyi O, Akintan P, Salako A, Omotosho O, Temiye E PLoS One. 2020; 15(12):e0243656.
PMID: 33301507 PMC: 7728231. DOI: 10.1371/journal.pone.0243656.
Platt L, French C, McGowan C, Sabin K, Gower E, Trickey A J Viral Hepat. 2019; 27(3):294-315.
PMID: 31603999 PMC: 7383613. DOI: 10.1111/jvh.13217.
Adetokunboh O, Awotiwon A, Ndwandwe D, Uthman O, Wiysonge C Hum Vaccin Immunother. 2019; 15(11):2590-2605.
PMID: 30945963 PMC: 6930054. DOI: 10.1080/21645515.2019.1599676.